Obsessive-Compulsive Disorder Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Obsessive-Compulsive Disorder Clinical Trial Market Report Overview
Obsessive-compulsive disorder clinical trial market research report provides top line data relating to the clinical trials on obsessive-compulsive disorder. The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials.
Key Regions | · North America
· Europe · Asia-Pacific · Middle East and Africa · South and Central America |
Key Countries | · The United States
· Iran · China · India · Canada |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · F. Hoffmann-La Roche Ltd
· Pfizer Inc · Novartis AG · Viatris Inc · The Lundbeck Foundation · Torrent Investments Pvt Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Obsessive-Compulsive Disorder Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the obsessive-compulsive disorder clinical trials landscape with a significant number of the clinical trials conducted as of March 2024.
The key regions considered for obsessive-compulsive disorder clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In the country-wise analysis, the US had the highest number of obsessive-compulsive disorder clinical trials, as of March 2024. The UK had the highest average patient enrollment of obsessive-compulsive disorder clinical trials, during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Canada had the highest proportion of obsessive-compulsive disorder to Central Nervous System clinical trials as of March 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia had the highest proportion of obsessive-compulsive disorder to central nervous system clinical trials as of March 2024.
Obsessive-Compulsive Disorder Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Obsessive-Compulsive Disorder Clinical Trials Download a Free Report Sample
Obsessive-Compulsive Disorder Clinical Trials Segmentation by Sponsor Types
The key sponsor types for obsessive-compulsive disorder clinical trials are company, institution, and the government. As of March 2024, a significant percentage of obsessive-compulsive disorder clinical trials conducted were sponsored by institution sponsor type.
Obsessive-Compulsive Disorder Clinical Trials Analysis by Sponsor Type, 2024 (%)
Buy the Full Report for More Insights into the Obsessive-Compulsive Disorder Clinical Trials Sponsor Types Download a Free Report Sample
Obsessive-Compulsive Disorder Clinical Trials - Competitive Landscape
- Hoffmann-La Roche Ltd conducted the highest number of obsessive-compulsive disorder clinical trials as of March 2024.
A few of the other prominent sponsors in the obsessive-compulsive disorder clinical trials market are:
- Pfizer Inc
- Novartis AG
- Viatris Inc
- The Lundbeck Foundation
- Torrent Investments Pvt Ltd
Obsessive-Compulsive Disorder Clinical Trials Analysis by Sponsors, 2024 (%)
Buy the Full Report to Know More About the Leading Sponsors of Obsessive-Compulsive Disorder Clinical Trials
Segments Covered in the Report
Obsessive-Compulsive Disorder Clinical Trials Regional Outlook (2024)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Obsessive-Compulsive Disorder Clinical Trials Country Outlook (2024)
- The United States
- Iran
- China
- India
- Canada
Obsessive-Compulsive Disorder Clinical Trials Sponsor Type Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type and end point status.
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment.
- The report provides enrollment trends for the past five years.
- The report provides latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trials count and enrollment trends by country in global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional and country level.
Pfizer Inc
Novartis AG
Viatris Inc
The Lundbeck Foundation
Torrent Investments Pvt Ltd
AbbVie Inc
AstraZeneca Plc
Patient Square Capital LP
Sandoz Group AG
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of obsessive-compulsive disorder clinical trials in March 2024?
Asia-Pacific accounted for the highest number of obsessive-compulsive disorder clinical trials as of March 2024.
-
Which country conducted the highest number of obsessive-compulsive disorder clinical trials in March 2024?
The US conducted the highest number of obsessive-compulsive disorder clinical trials as of March 2024.
-
Which sponsor type was the most prominent in the obsessive-compulsive disorder clinical trials in March 2024?
As of March 2024, most of the obsessive-compulsive disorder clinical trials conducted were sponsored by institution sponsor type.
-
Who are the leading sponsors of obsessive-compulsive disorder clinical trials?
A few of the leading sponsors of obsessive-compulsive disorder clinical trials are F. Hoffmann-La Roche Ltd, Pfizer Inc, Novartis AG, Viatris Inc, The Lundbeck Foundation, and Torrent Investments Pvt Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.